Hoya Corp (HOCPF)
125.54
+2.30
(+1.87%)
USD |
OTCM |
May 31, 16:00
Hoya Enterprise Value: 40.56B for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 40.56B |
| May 30, 2024 | 39.76B |
| May 29, 2024 | 39.25B |
| May 28, 2024 | 38.57B |
| May 24, 2024 | 39.05B |
| May 23, 2024 | 39.36B |
| May 22, 2024 | 39.32B |
| May 21, 2024 | 39.32B |
| May 20, 2024 | 39.32B |
| May 17, 2024 | 39.71B |
| May 16, 2024 | 40.76B |
| May 15, 2024 | 39.98B |
| May 14, 2024 | 36.03B |
| May 13, 2024 | 38.53B |
| May 10, 2024 | 36.40B |
| May 09, 2024 | 36.49B |
| May 08, 2024 | 39.44B |
| May 07, 2024 | 39.44B |
| May 06, 2024 | 39.44B |
| May 03, 2024 | 36.93B |
| May 02, 2024 | 36.93B |
| May 01, 2024 | 37.26B |
| April 30, 2024 | 36.93B |
| April 29, 2024 | 36.66B |
| April 26, 2024 | 35.61B |
| Date | Value |
|---|---|
| April 25, 2024 | 35.61B |
| April 24, 2024 | 35.61B |
| April 23, 2024 | 35.61B |
| April 22, 2024 | 36.17B |
| April 19, 2024 | 35.87B |
| April 18, 2024 | 35.87B |
| April 17, 2024 | 36.09B |
| April 16, 2024 | 35.44B |
| April 15, 2024 | 34.38B |
| April 12, 2024 | 34.56B |
| April 11, 2024 | 34.47B |
| April 10, 2024 | 35.24B |
| April 09, 2024 | 36.40B |
| April 08, 2024 | 38.68B |
| April 05, 2024 | 38.68B |
| April 04, 2024 | 38.68B |
| April 03, 2024 | 41.55B |
| April 02, 2024 | 41.55B |
| April 01, 2024 | 41.55B |
| March 31, 2024 | 41.55B |
| March 28, 2024 | 41.79B |
| March 27, 2024 | 41.79B |
| March 26, 2024 | 41.54B |
| March 25, 2024 | 41.54B |
| March 22, 2024 | 41.54B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
23.08B
Minimum
Jun 04 2019
60.61B
Maximum
Sep 15 2021
37.52B
Average
35.50B
Median
Apr 13 2023
Enterprise Value Benchmarks
| Takeda Pharmaceutical Co Ltd | 70.78B |
| Nxera Pharma Co Ltd | 932.97M |
| PeptiDream Inc | 1.615B |
| Healios KK | 57.40M |
| AnGes Inc | 59.01M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 379.25M |
| Revenue (Quarterly) | 1.390B |
| Total Expenses (Quarterly) | 627.86M |
| EPS Diluted (Quarterly) | 1.096 |
| Gross Profit Margin (Quarterly) | 87.03% |
| Profit Margin (Quarterly) | 27.29% |
| Earnings Yield | 2.84% |
| Operating Earnings Yield | 6.79% |
| Normalized Earnings Yield | 2.944 |